Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled “Glenmark Pharmaceuticals receives U.SFDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray”|SUBJECT: Press Release
Source link
Related Posts
Coimbatore City Municipal Corporation
Coimbatore City Municipal Corporation has informed the Exchange regarding Annual Financial Results Updates of the company for the period ended…
Alivus Life Sciences Limited
Alivus Life Sciences Limited has informed the Exchange that Record date for the purpose of Dividend is 01-Sep-2026|SUBJECT: Record…
Government Clears Minda Instruments to Manufacture Display Modules Under ECMS
Minda Instruments Limited, a wholly owned subsidiary of Minda Corporation and part of the Spark Minda Group, has received…